NORTHWEST BIOTHERAPEUTICS INC
Clinical trial NCT06096311 updates: 1. status: RECRUITING → COMPLETED 2. primary completion date: 2025-12-01 → 2024-08-07 3. enrollment: 30 → 35 participants 4. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT06096311 updates: 1. status: RECRUITING → COMPLETED 2. primary completion date: 2025-12-01 → 2024-08-07 3. enrollment: 30 → 35 participants 4. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical